127 related articles for article (PubMed ID: 1409792)
1. Long-term influence of d-amphetamine on mesolimbic brain-stimulation reward: comparison to chronic haloperidol and naloxone effects.
Borowski TB; Kokkinidis L
Pharmacol Biochem Behav; 1992 Sep; 43(1):1-15. PubMed ID: 1409792
[TBL] [Abstract][Full Text] [Related]
2. Sensitization of mesolimbic brain stimulation reward after electrical kindling of the amygdala.
Kokkinidis L; Borowski TB
Brain Res Bull; 1991 Dec; 27(6):791-6. PubMed ID: 1786555
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of mesolimbic behavioral supersensitivity by naloxone.
Seeger TF; Nazzaro JM; Gardner EL
Eur J Pharmacol; 1980 Aug; 65(4):435-8. PubMed ID: 7408948
[TBL] [Abstract][Full Text] [Related]
4. Chronic haloperidol-amphetamine interactions and mesolimbic dopamine.
Lynch MR; Kuhn HG; Carey RJ
Neuropsychobiology; 1988; 19(2):97-103. PubMed ID: 3226530
[TBL] [Abstract][Full Text] [Related]
5. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
Liu J; Schulteis G
Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
[TBL] [Abstract][Full Text] [Related]
6. Catecholamines and endogenous opioids in ventral tegmental self-stimulation reward.
van Wolfswinkel L; Seifert WF; van Ree JM
Pharmacol Biochem Behav; 1988 Jul; 30(3):589-95. PubMed ID: 3211968
[TBL] [Abstract][Full Text] [Related]
7. Reward system depression following chronic amphetamine: antagonism by haloperidol.
Barrett RJ; White DK
Pharmacol Biochem Behav; 1980 Oct; 13(4):555-9. PubMed ID: 7433486
[TBL] [Abstract][Full Text] [Related]
8. Repeated electroconvulsive shock attenuates the depressive-like effects of d-amphetamine withdrawal on brain reward function in rats.
Barr AM; Zis AP; Phillips AG
Psychopharmacology (Berl); 2002 Jan; 159(2):196-202. PubMed ID: 11862349
[TBL] [Abstract][Full Text] [Related]
9. Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds.
Wise RA; Munn E
Psychopharmacology (Berl); 1995 Jan; 117(2):130-6. PubMed ID: 7753958
[TBL] [Abstract][Full Text] [Related]
10. Intracranial self-stimulation under a progressive-ratio schedule in rats: effects of strength of stimulation, d-amphetamine, 7-OH-DPAT and haloperidol.
Depoortere R; Perrault G; Sanger DJ
Psychopharmacology (Berl); 1999 Mar; 142(3):221-9. PubMed ID: 10208313
[TBL] [Abstract][Full Text] [Related]
11. Effects of d-amphetamine and naloxone on brain stimulation reward.
Esposito RU; Perry W; Kornetsky C
Psychopharmacology (Berl); 1980; 69(2):187-91. PubMed ID: 6779312
[TBL] [Abstract][Full Text] [Related]
12. Effects of haloperidol and d-amphetamine on perceived quantity of food and tones.
Martin-Iverson MT; Wilkie D; Fibiger HC
Psychopharmacology (Berl); 1987; 93(3):374-81. PubMed ID: 3124167
[TBL] [Abstract][Full Text] [Related]
13. Clozapine's functional mesolimbic selectivity is not duplicated by the addition of anticholinergic action to haloperidol: a brain stimulation study in the rat.
Gardner EL; Walker LS; Paredes W
Psychopharmacology (Berl); 1993; 110(1-2):119-24. PubMed ID: 7870870
[TBL] [Abstract][Full Text] [Related]
14. Enhanced reward-facilitating effects of d-amphetamine in rats in the quinpirole model of obsessive-compulsive disorder.
Schmidt TT; Rea E; Shababi-Klein J; Panagis G; Winter C
Int J Neuropsychopharmacol; 2013 Jun; 16(5):1083-91. PubMed ID: 23043789
[TBL] [Abstract][Full Text] [Related]
15. Actions and interactions of amphetamine on self-stimulation in rats.
Aulakh CS; Pradhan SN
Pharmacol Biochem Behav; 1979 Sep; 11(3):351-4. PubMed ID: 41267
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs.
Lin D; Koob GF; Markou A
Psychopharmacology (Berl); 1999 Aug; 145(3):283-94. PubMed ID: 10494577
[TBL] [Abstract][Full Text] [Related]
17. Conditioned withdrawal drives heroin consumption and decreases reward sensitivity.
Kenny PJ; Chen SA; Kitamura O; Markou A; Koob GF
J Neurosci; 2006 May; 26(22):5894-900. PubMed ID: 16738231
[TBL] [Abstract][Full Text] [Related]
18. Electrical sensitization of the meso-limbic dopaminergic system in rats: a pathogenetic model for schizophrenia.
Glenthøj B; Mogensen J; Laursen H; Holm S; Hemmingsen R
Brain Res; 1993 Aug; 619(1-2):39-54. PubMed ID: 8374792
[TBL] [Abstract][Full Text] [Related]
19. Effects of the D(3) dopamine receptor antagonist, U99194A, on brain stimulation and d-amphetamine reward, motor activity, and c-fos expression in ad libitum fed and food-restricted rats.
Carr KD; Yamamoto N; Omura M; Cabeza de Vaca S; Krahne L
Psychopharmacology (Berl); 2002 Aug; 163(1):76-84. PubMed ID: 12185403
[TBL] [Abstract][Full Text] [Related]
20. Opposite effects of PCA and chlorimipramine on ICSS and on its facilitation by amphetamine.
Olds ME
Pharmacol Biochem Behav; 1994 Apr; 47(4):803-17. PubMed ID: 8029248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
